Search

Search Results

• Exercise effects on adipokines and the IGF axis in men with prostate cancer treated with androgen deprivation: A randomized study

  Daniel Santa Mina, Michael K. Connor, Shabbir M.H. Alibhai, Paul Toren, Crissa Guglietti, Andrew G. Matthew, John Trachtenberg, Paul Ritvo

  e692-8

  2013-11-08

• Who’s too old to screen? Prostate cancer in elderly men

  Sandeep Mistry, Wesley Mayer, Rose Khavari, Gustavo Ayala, Brian Miles

  205-10

• The role of PSA density to predict a pathological tumour upgrade between needle biopsy and radical prostatectomy for low risk clinical prostate cancer in the modified Gleason system era

  Stavros Sfoungaristos, Ioannis Katafigiotis, Petros Perimenis

  e722-7

  2013-11-08

• The 20-core prostate biopsy as an initial strategy: impact on the detection of prostatic cancer

  Mohamed Amine Jradi, Mohamed Dridi, Mourad Teyeb, Mokhtar Ould Sidi Mohamed, Ramzi Khiary, Samir Ghozzi, Nawfel Ben Rais

  100-4

• Surgical margin status among men with organ-confined (pT2) prostate cancer: a population-based study

  Nathan Lawrentschuk, Andrew Evans, John Srigley, Joseph L. Chin, Bish Bora, Amber Hunter, Robin McLeod, Neil E. Fleshner

  161-6

• The incidence of prostate cancer and urothelial cancer in the prostate in cystoprostatectomy specimens in a tertiary care Canadian centre

  Sri Sivalingam, Darrel Drachenberg

  35-8

  2013-02-20

• Next-generation prostate cancer risk calculator for primary care physicians

  Robert K. Nam, Raj Satkunasivam, Joseph L. Chin, Jonathan Izawa, John Trachtenberg, Ricardo Rendon, David Bell, Rajiv Singal, Christopher Sherman, Linda Sugar, Kevin Chagin, Michael W. Kattan

  E64-70

  2017-12-01

• Survival after radical prostatectomy and radiotherapy for prostate cancer: a population-based study

  Claudio Jeldres, Nazareno Suardi, Paul Perrotte, Umberto Capitanio, Jochen Walz, Georg C. Hutterer, Fred Saad, Luc Valiquette, Markus Graefen, Hugues Widmer, Pierre I. Karakiewicz

  13-21

• Furthering the prostate cancer screening debate (prostate cancer specific mortality and associated risks)

  G. Michael Allan, Michael P. Chetner, Bryan J. Donnelly, Neil A. Hagen, David Ross, J. Dean Ruether, Peter Venner

  416-21

• Nonsteroidal anti-inflammatory drugs and prostate cancer: a systematic review of the literature and meta-analysis

  Siavash Jafari, Mahyar Etminan, Kourosh Afshar

  323-30

• Dietary habits and prostate cancer detection: a case–control study

  Moamen Amin, Suganthiny Jeyaganth, Nader Fahmy, Louis R. Bégin, Samuel Aronson, Stephen Jacobson, Simon Tanguay, Wassim Kassouf, Armen Aprikian

  510-5

• Evaluation of neutrophil-to-lymphocyte ratio prior to prostate biopsy to predict biopsy histology: Results of 1836 patients

  Mehmet Ilker Gokce, Nurullah Hamidi, Evren Suer, Semih Tangal, Adil Huseynov, Arif Ibiş

  E761-5

  2015-11-04

• Wait times in prostate cancer diagnosis and radiation treatment

  Christiaan Stevens, Susan J. Bondy, D. Andrew Loblaw

  243-8

• A population-based study examining the influence of a specialized rapid-access cancer clinic on initial treatment choice in localized prostate cancer

  Larissa J. Vos, Clement K. Ho, Bryan J. Donnelly, J. Dean Reuther, Marc Kerba

  E314-7

  2018-03-15

• An environmental scan of sexual health services for cancer survivors among Canadian institutions NEED

  Ryan Flannigan, Andrew Matthew, Sydney Sparanese, Eugenia Wu, Steven Guirguis, Monita Sundar, Fred Saad, Andrew Loblaw, Jessica Nargi, Luke Witherspoon, Christina Canil, Ricardo A. Rendon, Laura Labelle, Jill Turner, Celestia Higano

  61-3

  2022-09-30

• Pre-treatment risk stratification of prostate cancer patients:A critical review

  George Rodrigues, Padraig Warde, Tom Pickles, Juanita Crook, Michael Brundage, Luis Souhami, Himu Lukka

  2012-12-13

• Real-world management of advanced prostate cancer: A description of management practices of community-based physicians and prostate cancer specialists

  Sebastien J. Hotte, Antonio Finelli, Kim N. Chi, Christina Canil, Neil Fleshner, Anil Kapoor, Michael Kolinsky, Shawn Malone, Christopher Morash, Tamim Niazi, Krista L. Noonan, Michael Ong, Frederic Pouliot, Bobby Shayegan, Alan I. So, Delna Sorabji, Huong Hew, Laura Park-Wyllie, Fred Saad

  E90-6

  2020-08-18

• Does adding local salvage ablation therapy provide survival advantage for patients with locally recurrent prostate cancer following radiotherapy? Whole gland salvage ablation post-radiation failure in prostate cancer

  Shiva Madhwan Nair, Andrew Warner, Arnon Lavi, George Rodrigues, Joseph L. Chin

  123-9

  2020-09-28

• Preoperative parameters to predict incidental (T1a and T1b) prostate cancer

  Hirofumi Sakamoto, Kazuhiro Matsumoto, Nozomi Hayakawa, Takahiro Maeda, Atsuko Sato, Akiharu Ninomiya, Kiyoshi Mukai, So Nakamura

  e815-20

  2014-11-24

• Radical prostatectomy for high-risk clinically localized prostate cancer: a prospective single institution series

  Anthony J. Koupparis, Jeremy P. Grummet, Antonio Hurtado-Coll, Robert H. Bell, Nicholas Buchan, Larry Goldenberg, Martin E. Gleave

  E156-E161

• Urothelial Cancer and the Diagnosis of Subsequent Malignancies

  Deepak K. Pruthi, Zoann Nugent, Piotr Czaykowski, Alain A. Demers

  E57-64

  2013-02-20

• The evolving role of germline genetic testing and management in prostate cancer: Report from the Princess Margaret Cancer Centre international retreat

  Roderick Clark, Miran Kenk, Kristen McAlpine, Emily Thain, Kirsten M. Farncombe, Colin C. Pritchard, Robert Nussbaum, Alexander W. Wyatt, Johann de Bono, Danny Vesprini, Yvonne Bombard, Justin Lorentz, Steven Narod, Raymond Kim, Neil Fleshner

  E623-9

  2021-06-22

• Prediction of prostate cancer by deep learning with multilayer artificial neural network

  Takumi Takeuchi, Mami Hattori-Kato, Yumiko Okuno, Satoshi Iwai, Koji Mikami

  2018-10-15

• Incidentalomas of the prostate detected by 18-fluoro-2-deoxy-Dglucose positron emission tomography/computed tomography

  Miles P. Mannas, Taeweon Lee, Maral Pourghiasian, Don C. Wilson, Peter C. Black

  E180-4

  2019-11-29

• Results from a Canadian consensus forum of key controversial areas in the management of advanced prostate cancer: Recommendations for Canadian healthcare providers

  Fred Saad, Sebastien J. Hotte, Antonio Finelli, Shawn Malone, Tamim Niazi, Krista Noonan, Bobby Shayegan, Alan I. So, Brita Danielson, Naveen S. Basappa, Ilias Cagiannos, Christina Canil, Guila Delouya, Ricardo Fernandes, Cristiano Ferrario, Geoffrey T. Gotto, Robert J. Hamilton, Jason P. Izard, Anil Kapoor, Daniel Khalaf, Michael Kolinsky, Aly-Khan Lalani, Luke T. Lavallée, Christopher Morash, Scott C. Morgan, Michael Ong, Frédéric Pouliot, Ricardo A. Rendon, Steven Yip, Anousheh Zardan, Laura Park-Wyllie, Kim Chi

  353-8

  2021-10-04

• Role for ¹¹C-choline PET in active surveillance of prostate cancer

  Oleksandr Boychak, Larissa Joy Vos, William Makis, Francois-Alexandre Buteau, Nadeem Pervez, Matthew Parliament, Alexander JB McEwan, Nawaid Usmani

  e98-103

  2015-03-11

• Incidence and mortality trends of metastatic prostate cancer: Surveillance, Epidemiology, and End Results database analysis

  Aaron C. Zhang, Rehana Rasul, Anne Golden, Michael A. Feuerstein

  E637-43

  2021-06-22

• Prostate cancer screening characteristics in men with BRCA1/2 mutations attending a high-risk prevention clinic

  Richard Walker, Alyssa Louis, Alejandro Berlin, Sheri Horsburgh, Robert G. Bristow, John Trachtenberg

  e783-8

  2014-11-24

• Does perineural invasion in a radical prostatectomy specimen predict biochemical recurrence in men with prostate cancer?

  Fairleigh Reeves, Christopher M. Hovens, Laurence Harewood, Shayne Battye, Justin S. Peters, Anthony J. Costello, Niall M. Corcoran

  E252-5

  2015-05-13

• The effect of dutasteride on the detection of prostate cancer: A set of meta-analyses

  Neerav Monga, Amyn Sayani, Daniel A. Rubinger, Timothy H. Wilson, Zhen Su

  E161-167

  2013-03-21

• A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration resistant prostate cancer

  Ravinder Clayton, Jackson Wu, Daniel Y Heng, Scott A North, Urban Emmenegger, Sebastien Hotte, Kim Chi, Rob Zielinski, Humaid Al-Shamsi, Leo Chen, Bernhard Eigl

  e583-90

  2014-09-09

• Current topics in radiotherapy for genitourinary cancers: Consensus statements of the Genitourinary Radiation Oncologists of Canada

  Scott C. Morgan, Gerard C. Morton, Alejandro Berlin, Patrick Cheung, Peter Chung, Cynthia Ménard, Tom Pickles, Luis Souhami, Padraig R. Warde, Himanshu R. Lukka

  E588-93

  2020-07-16

• Recommendations by Canadian urologists and radiation oncologists for the treatment of clinically localized prostate cancer

  Andrew Pearce, Chris Newcomb, Siraj Husain

  197-203

• Comparison of 8, 10, 12, 16, 20 cores prostate biopsies in determination of prostate cancer and importance of prostate volume

  Cavit Ceylan, Omer Gokhan Doluoglu, Erdogan Aglamis, Ozkan Baytok

  e81-5

  2014-02-12

• Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum

  Fred Saad, Christina Canil, Antonio Finelli, Sebastien J. Hotte, Shawn Malone, Bobby Shayegan, Alan I. So, Lorne Aaron, Naveen S. Basappa, Henry J. Conter, Brita Danielson, Geoffrey Gotto, Robert J. Hamilton, Jason P. Izard, Anil Kapoor, Michael Kolinsky, Aly-Khan A. Lalani, Jean-Baptiste Lattouf, Christopher Morash, Scott C. Morgan, Tamim Niazi, Krista L. Noonan, Michael Ong, Ricardo A. Rendon, Sandeep Sehdev, Huong Hew, Laura Park-Wyllie, Kim N. Chi`

  E137-49

  2019-11-05

• Active surveillance for the management of localized prostate cancer: Guideline recommendations

  Chris Morash, Rovena Tey, Chika Agbassi, Laurence Klotz, Tom McGowan, John Srigley, Andrew Evans

  171-8

  2015-06-15

• Dynamic contrast enhanced MRI as a predictor of vascular-targeted photodynamic focal ablation therapy outcome in prostate cancer post failed external beam radiation therapy

  Tristan Barrett, Sean R.H. Davidson, Brian C. Wilson, Robert A. Weersink, John Trachtenberg, Masoom A. Haider

  e708-14

  2014-10-22

• Diagnostic accuracy of surface coil magnetic resonance imaging at 1.5 T for local staging of elevated risk prostate cancer

  Brian Kim, Rodney H. Breau, Demetri Papadatos, Dean Fergusson, Steve Doucette, Ilias Cagiannos, Chris Morash

  257-62

• Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL

  Stéphane Bolduc, Louis Lacombe, Alain Naud, Mireille Grégoire, Yves Fradet, Roland R. Tremblay

  377-81

• Detection of clinically significant prostate cancer by micro-ultrasound-informed systematic biopsy during MRI/micro-ultrasound fusion biopsy

  Betty Wang, Stacey Broomfield, Anaïs Medina Martín, Patrick Albers, Christopher Fung, Adam Kinnaird

  2022-12-06

• How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer?

  Ege Can Serefoglu, Serkan Altinova, Nevzat Serdar Ugras, Egemen Akincioglu, Erem Asil, Derya Balbay

  e293-8

  2013-05-13

• Prostate cancer-specific survival differences in patients treated by radical prostatectomy versus curative radiotherapy

  Julie M. DeGroot, Michael D. Brundage, Miu Lam, Susan L. Rohland, Jeremy Heaton, William J. Mackillop, D. Robert Siemens, Patti A. Groome

  e299-305

  2013-05-13

• Management algorithms for metastatic prostate cancer

  Shawn Malone, Bobby Shayegan, Naveen S. Basappa, Kim Chi, Henry J. Conter, Robert J. Hamilton, Sebastien J. Hotte, Fred Saad, Alan I. So, Laura Park-Wyllie, Huong Hew, Deanna McLeod, Geoffrey Gotto

  50-60

  2019-04-26

• Predictors of prostate cancer survivors’ engagement in selfmanagement behaviors

  Eleni Giannopoulos, Charles Catton, Meredith Elana Giuliani, Edward Kucharski, Andrew Matthew, Naa Kwarley Quartey, Janet Papadakos

  49-60

  2022-09-30

• High-intensity focused ultrasound for prostate cancer: a practice guideline

  Himu Lukka, Tricia Waldron, Joseph Chin, Linda Mayhew, Padraig Warde, Eric Winquist, George Rodrigues, Bobby Shayegan

  232-6

• An assessment of Prostate Cancer Research International: Active Surveillance (PRIAS) criteria for active surveillance of clinically low-risk prostate cancer patients

  Vitor da Silva, Ilias Cagiannos, Luke T. Lavallée, Ranjeeta Mallick, Kelsey Witiuk, Sonya Cnossen, James A. Eastham, Dean A. Fergusson, Chris Morash, Rodney H. Breau

  238-43

  2017-08-11

• Epidemiology of prostate and kidney cancer in the Aboriginal population of Canada: A systematic review

  Emily Chu Lee Wong, Anil Kapoor

  E222-32

  2017-05-09

• Synchronous primary malignancies of the male urogenital tract

  Abdelmounaim Qarro, Abdelghani Ammani, Khalil Bazine, Mohammed Najoui, Jamaleddine Samir, Mohammed Alami

  e353-5

  2014-05-21

• Prospective comparison of the impact of robotic-assisted laparoscopic radical prostatectomy versus open radical prostatectomy on health-related quality of life and decision regret

  Barbara Joyce Davison, Andrew Matthew, Abbie M. Gardner

  e68-72

  2014-01-14

• Prostate cancer risk group is associated with other-cause mortality in men with localized prostate cancer

  Rehana Rasul, Anne Golden, Michael A. Feuerstein

  E507-13

  2020-05-12